SM
BNTCW

Sabby Management’s Benitec Biopharma Limited BNTCW Stock Holding History

Sabby Management’s Portfolio BNTCW Stock Details BNTCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-51,449
Closed -$1K – 102
2019
Q3 		$1K Sell
51,449
-5,500
-10% -$168 ﹤0.01% 93
2019
Q2 		$1K Sell
56,949
-1,000
-2% -$99 ﹤0.01% 88
2019
Q1 		$6K Sell
57,949
-101
-0.2% -$15 ﹤0.01% 75
2018
Q4 		$7K Hold
58,050
– – ﹤0.01% 118
2018
Q3 		$7K Sell
58,050
-17,854
-24% -$8.3K ﹤0.01% 120
2018
Q2 		$8K Buy
+75,904
New +$23K ﹤0.01% 134
2018
Q1 		– Sell
-90,193
Closed -$31.9K – 210
2017
Q4 		$36K Hold
90,193
– – ﹤0.01% 148
2017
Q3 		$27K Hold
90,193
– – ﹤0.01% 157
2017
Q2 		$32K Sell
90,193
-34,970
-28% -$12.2K ﹤0.01% 207
2017
Q1 		$37K Buy
125,163
+27,017
+28% +$9.35K ﹤0.01% 252
2016
Q4 		$10K Buy
+98,146
New +$9.9K ﹤0.01% 292

Other funds holding BNTCW

CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Sabby Management's BNTCW Position: Q4 2019 in Review

Sabby Management sold out of Benitec Biopharma Limited (BNTCW) in Q4 2019, closing a stake of 51,449 shares — an estimated $1K sold.

Sabby Management first reported a position in BNTCW in Q4 2016 and held it in 11 quarters. The position peaked at $37K in Q1 2017. 1 fund tracked by Wall St. Rank holds BNTCW as of Q4 2019.

  • Sabby Management reported no remaining Benitec Biopharma Limited position as of Q4 2019 after selling out during the quarter.
  • Sabby Management sold 51,449 Benitec Biopharma Limited shares in Q4 2019, an estimated $1K.
  • Sabby Management first reported a position in Benitec Biopharma Limited in Q4 2016 and held it in 11 quarters.
  • Sabby Management's Benitec Biopharma Limited position peaked at $37K in Q1 2017.
  • 1 fund tracked by Wall St. Rank held Benitec Biopharma Limited as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.